Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

China flag China · Delayed Price · Currency is CNY
11.44
+0.11 (0.97%)
At close: Mar 10, 2026
42.64%
Market Cap 5.71B
Revenue (ttm) 924.04M
Net Income (ttm) 79.70M
Shares Out 499.27M
EPS (ttm) 0.18
PE Ratio 62.85
Forward PE 39.45
Dividend 0.05 (0.44%)
Ex-Dividend Date Jul 25, 2025
Volume 11,887,590
Average Volume 31,135,890
Open 11.40
Previous Close 11.33
Day's Range 11.38 - 11.48
52-Week Range 6.86 - 15.21
Beta 2.05
RSI 42.84
Earnings Date Mar 24, 2026

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company provides cough and phlegm, kidney, anti-infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, respiratory, rheumatology, nephrology, and endocrinology medicines. Its chemical raw materials and products include aluminum carbonate, phenytoin, ferrous... [Read more]

Sector Healthcare
Founded 2002
Employees 1,341
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002728
Full Company Profile

Financial Performance

In 2024, SHE:002728's revenue was 687.79 million, a decrease of -35.55% compared to the previous year's 1.07 billion. Earnings were 20.50 million, a decrease of -91.90%.

Financial Statements

News

There is no news available yet.